The economic burden of stroke in 2010 in Korea

Kim, Hyun Jin; Kim, Young Ae; Seo, Hye Young; Kim, Eun Jung; Yoon, Seok Jun; Oh, In Hwan

doi:10.5124/jkma.2012.55.12.1226

Cited by 21 publications

(21 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, the total costs of hepatitis A, B, and C (US $744.1 million) was higher than that of epilepsy (US $525.5 million, as of 2010) (29) and only slightly lower than that of asthma (US $786.1 million, as of 2008) (15). However, the economic burdens of colorectal cancer, stroke, and musculoskeletal disease were 4.1, 4.7, and 9.3 times greater than those of hepatitis, respectively (17,28,30). Furthermore, one of the indicators of comparable estimation is the percentage of gross domestic product (GDP).…”

Section: Discussionmentioning

confidence: 92%

The Economic Burden of Hepatitis A, B, and C in South Korea

et al. 2016

Self Cite

View full text Add to dashboard Cite

SUMMARY:The prevalence of hepatitis in South Korea is relatively high compared to that in other high-income countries. For this reason, viral hepatitis infection not only affects the population's health, but also impacts national healthcare costs. This study was performed in order to estimate the individual economic costs of the hepatitis A, B, and C viruses as well as to determine, using nationally representative data, the trends in South Korea with respect to these viruses during the 2008-2011 period. The study found that the prevalence of hepatitis A had decreased, but those of hepatitis B and C had increased overall. The mortality rate of hepatitis C was higher than that of the other two types. The mortality rate of hepatitis B had changed little, whereas that of hepatitis C had risen.

show abstract

Section: Discussionmentioning

confidence: 92%

The Economic Burden of Hepatitis A, B, and C in South Korea

et al. 2016

Self Cite

View full text Add to dashboard Cite

show abstract

“…Recently, cost-of-illness studies have continued to progress in order to estimate the impact of diseases with similar frameworks in Korea. Stroke burden evaluations in 2010 estimated direct costs to be $3.528 billion USD, which was much higher than the direct cost of AMI in our 2012 evaluation [ 24 ]. Additionally, the economic costs of coronary heart diseases (CHD), including AMI, were estimated at $2.518 billion USD, and 38% of this cost ($954 million USD) was attributed to myocardial infarction [ 25 ].…”

Section: Discussionmentioning

confidence: 93%

Recent Trends in Economic Burden of Acute Myocardial Infarction in South Korea

Seo

Yoon

et al. 2015

PLoS ONE

Self Cite

View full text Add to dashboard Cite

In 2010, ischemic heart disease was the leading cause of disability-adjusted life-years (DALYs) worldwide. More specially, the prevalence of acute myocardial infarctions (AMI) is increasing in the aged population as mortality decreases; South Korea is no exception. This study aims to examine the economic burden of AMI in the Korean population between 2007 and 2012. AMI-related costs were assessed from a societal perspective. A prevalence-based cost-of-illness framework was used for this analysis. The subjects included all South Koreans with AMI-related ICD-10 codes (I21, I22, I23, I25.0, and I25.1). Data on direct (medical and non-medical) costs and indirect (productivity loss due to AMI-associated morbidity and mortality) costs were collected from the Korean National Health Insurance Service’s claims data. The human capital approach was used to calculate indirect costs. The total estimated cost of AMI in 2012 was $1,177,649,323 USD. The majority (52%) of this amount was made up of medical costs, followed by productivity losses due to mortality and morbidity (42% of annual cost). Although the total cost declined by approximately 18% compared to 2007 ($1,427,643,854 USD), the cost of AMI in the over 60 age group amounted to 47% of the total cost of AMI in 2012. AMI led to a high economic burden in 2012. This study, which identified not only the size, but also the trends of AMI-related costs, will provide information to evaluate effects of governmental health projects and the effective allocation of public research funds.

show abstract

“…However, prevalence of stroke is expected to further increase due to an aging population; likewise, the cost-burden due to stroke is also expected to rise in South Korea [4,5].…”

Section: Introductionmentioning

confidence: 99%